Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SHE/300562 stock hub

SHE/300562 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300562is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.2B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300562

In the news

Latest news · SHE/300562

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E35.3

P25 23.5P50 41.3P75 83.2

ROE8.8

P25 -0.9P50 4.1P75 8.8

ROIC30.5

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300562 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

CNY

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,089
Employees Change	-93%
Employees Change Percent	-7.87
Enterprise value	CNY 2.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Devices
Isin	CNE100002DJ6
Last refreshed	2026-05-10
Market cap	CNY 3.2B
Price	CNY 14.58
Price currency	CNY
Rev Per Employee	915,189.46x
Sector	Healthcare
Sic	3841
Symbol	she/300562
Website	https://www.lifesense.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.87%
EV Earnings	26.99x
EV/EBIT	22.25x
EV/EBITDA	18.51x
EV/FCF	16.61x
EV/Sales	2.47x
FCF yield	4.67%
P/B ratio	3.05x
P/E ratio	35.26x
P/S ratio	3.19x
PE Ratio10 Y	97.04x
PE Ratio3 Y	43.54x
PE Ratio5 Y	71.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.09%
EBITDA Margin	12.93%
FCF margin	14.86%
Gross margin	35.18%
Gross Profit	CNY 350.6M
Gross Profit Growth	0.28%
Gross Profit Growth Q	4.89%
Gross Profit Growth3 Y	21.01%
Gross Profit Growth5 Y	-1.01%
Net Income	CNY 91.1M
Net Income Growth	29.01%
Net Income Growth Q	39.8%
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Net Income Growth5 Y	3.14%
Pretax Margin	9.35%
Profit Margin	9.14%
Profit Per Employee	CNY 83,683
Profitable Years	3
ROA	4.69
Roa5y	0.87
ROCE	10.47
ROE	8.75
Roe5y	2.65
ROIC	30.52
Roic5y	5.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.25%
Cagr3y	17.82%
Cagr5y	-0.5%
Div CAGR3	10.07%
Div CAGR5	66.34%
EPS Growth	24.26
EPS Growth Q	33.36
EPS Growth Quarters	3
EPS Growth Years	3
EPS Growth5 Y	0.53
FCF Growth	12.96%
FCF Growth Q	55.63%
FCF Growth3 Y	215.95%
OCF Growth	-2.9%
OCF Growth Q	21.27%
OCF Growth10 Y	16.02%
OCF Growth3 Y	79.66%
OCF Growth5 Y	28.76%
Revenue Growth	-1.19x
Revenue Growth Q	3.82x
Revenue Growth Quarters	2x
Revenue Growth Years	2x
Revenue Growth3 Y	1x
Revenue Growth5 Y	-8.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.68
Assets	CNY 1.4B
Cash	CNY 740.5M
Current Assets	CNY 996M
Current Liabilities	CNY 352M
Debt	CNY 47M
Debt EBITDA	CNY 0.35
Debt Equity	CNY 0.05
Debt FCF	CNY 0.32
Equity	CNY 1B
Interest Coverage	70.3
Liabilities	CNY 367M
Long Term Assets	CNY 411.6M
Long Term Liabilities	CNY 15M
Net Cash	CNY 693.5M
Net Cash By Market Cap	CNY 21.84
Net Cash Growth	16.43%
Net Debt EBITDA	CNY -5.38
Net Debt Equity	CNY -0.67
Net Debt FCF	CNY -4.68
Tangible Book Value	CNY 1B
Tangible Book Value Per Share	CNY 4.62
WACC	5.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.83
Inventory Turnover	9.81
Net Working Capital	CNY -49.5M
Quick ratio	2.62
Working Capital	CNY 644M
Working Capital Turnover	CNY 1.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.82%
Dividend Growth	-0.38%
Dividend Growth Years	0%
Dividend per share	CNY 0.26
Dividend Years	9
Dividend Yield	1.78%
Last Dividend	CNY 0.13
Payout Ratio	68.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.25%
200-day SMA	14.57
3Y total return	63.56%
50-day SMA	13.74
50-day SMA vs 200-day SMA	50under200
5Y total return	-2.48%
All Time High	52.34
All Time High Change	-72.15%
All Time High Date	2017-03-23
All Time Low	5.86
All Time Low Change	148.68%
All Time Low Date	2016-11-16
ATR	0.44
Beta	0.28
Beta1y	0.76
Beta2y	0.94
Ch YTD	9.38
High	14.61
High52	17.77
High52 Date	2025-08-12
High52ch	-17.95%
Low	14.36
Low52	11.99
Low52 Date	2026-03-23
Low52ch	21.6%
Ma50ch	6.13%
Price vs 200-day SMA	0.08%
RSI	62
RSI Monthly	53.38
RSI Weekly	53.76
Sharpe ratio	0.34x
Sortino ratio	0.68
Total Return	-2.03%
Tr YTD	9.38
Tr1m	11.21%
Tr1w	1.82%
Tr3m	-0.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 110.5M
Operating Income Growth	80.87
Operating Income Growth Q	71.55
Operating Income Growth5 Y	4.42
Operating margin	11.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	146,102,327%
Net Borrowing	-140,317,089
Shares Insiders	31.97%
Shares Institutions	4.69%
Shares Out	217,751,188
Shares Qo Q	-0.14%
Shares Yo Y	3.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 148.1M
Average Volume	8,150,843.9x
Bv Per Share	4.86
CAPEX	CNY -10.8M
Ch1m	11.21
Ch1w	1.82
Ch1y	-0.55
Ch3m	-0.27
Ch3y	55.94
Ch5y	-8.36
Ch6m	1.96
Change	0.97%
Change From Open	1.25
Close	14.44
Days Gap	-0.28
Depreciation Amortization	18,289,829
Dollar Volume	93,992,011.2
Earnings Date	2026-08-12
EBIT	CNY 110.5M
EBITDA	CNY 128.8M
EPS	CNY 0.41
F Score	7
FCF	CNY 148.1M
FCF EV Yield	6.02x
FCF Per Share	CNY 0.68
Financing CF	-195,481,921
Fiscal Year End	December
Founded	2,002
Graham Number	6.72782
Graham Upside	-53.86
Income Tax	CNY 3.8M
Investing CF	-183,108,702
Is Primary Listing	1
Last Earnings Date	2026-04-10
Last Report Date	2026-03-31
Last Split Date	2017-04-18
Last Split Type	Forward
Lynch Fair Value	CNY 2.07
Lynch Upside	-85.82
Ma150	14.11
Ma150ch	3.34%
Ma20	13.91
Ma20ch	4.83%
Net CF	-224,293,415
Next Earnings Date	2026-08-12
Open	14.4
P FCF Ratio	21.43
P OCF Ratio	19.98
Payment Date	2025-08-26
Position In Range	88
Ppne	221,792,727
Price Date	2026-05-08
Price EBITDA	CNY 24.64
Ptbv Ratio	3.15
Relative Volume	0.79x
Revenue	996,641,323x
Tax By Revenue	0.38x
Tax Rate	4.06%
Tr6m	1.96%
Volume	6,446,640

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300562 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$0.26 annual per share

Payout ratio

+68.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+66.3%

0 consecutive years of growth

Total shareholder yield

-2.0%

Dividend yield + buyback yield combined

Performance

SHE/300562 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300562?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.7%

Share of float held by funds and institutions

Insider ownership

+32.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.8%

Negative means the company is buying back shares.

Technical

SHE/300562 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.0

Neutral momentum band

Price vs 200-day MA

+0.1%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

0.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300562

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300562 stock rating?

she/300562 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300562 analysis?

The full report lives at /stocks/she/300562/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300562?

The latest report frames she/300562 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300562 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.